mtm laboratories AG Establishes US Subsidiary, Naming Robert Silverman President.HEIDELBERG, Germany -- mtm laboratories AG, a developer of diagnostic products for the early detection of cancer, announced today the incorporation of a US subsidiary in Westborough, Massachusetts, a suburb of Boston. The subsidiary, mtm laboratories Inc., is wholly-owned by mtm laboratories AG, Heidelberg, Germany. It will be headed by Mr. Robert Silverman, who will serve as President. For the past 18 months, Mr. Silverman has provided strategic management consulting services to mtm through his company, RS Consulting. Prior to forming RS Consulting, Mr. Silverman served as the Senior Vice President of Commercial Operations for ViaCell, Inc. ViaCell is a biotechnology company focusing on the application of human cells as medicine in the treatment of human disease. From 1996-2001, Mr. Silverman held several senior executive positions with Cytyc Corporation, including Vice President of International and Vice President of Marketing. Cytyc is a leading medical device company focused on women's health Women's Health Definition Women's health is the effect of gender on disease and health that encompasses a broad range of biological and psychosocial issues. . In addition, Mr. Silverman has held senior management positions with Pasteur-Merieux Connaught, now a division of Sanofi Aventis, and Abbott Laboratories Pharmaceutical Products Division. The activities of the subsidiary will focus on business development and the marketing of mtm's biomarker-based products in the United States. It will increase mtm's presence and strategic position in the largest single market for products in the area of cancer screening and diagnosis. Peter Pack, CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of the parent company in Heidelberg, Germany, commented: "The subsidiary will allow us to directly address the US market. With Mr. Silverman, we have identified an executive with outstanding general management and marketing expertise, and an impressive track record of successfully introducing innovative products into the medical market". Mr. Silverman, President of the US subsidiary, commented: "I am very excited about the opportunity to commercialize mtm's innovative, biomarker-based products for the early detection and diagnosis of cervical cancer Cervical Cancer Definition Cervical cancer is a disease in which the cells of the cervix become abnormal and start to grow uncontrollably, forming tumors. . I am looking forward to successfully expanding mtm's operation into the US." About mtm laboratories AG: mtm laboratories AG, founded in 1999 as a spin-off of the German Cancer Research Center The German Cancer Research Center (known as the Deutsches Krebs Forschungs Zentrum or simply DKFZ in German), is a cancer research center based in Heidelberg, Germany. It is a member of the Helmholtz Association, the largest scientific organization in Germany. (DKFZ DKFZ Deutsches Krebsforschungszentrum (German Cancer Research Center, Heidelberg, Germany) ), is a privately held company privately held company A firm whose shares are held within a relatively small circle of owners and are not traded publicly. based in Heidelberg, Germany. The company develops In Vitro in vitro /in vi·tro/ (in ve´tro) [L.] within a glass; observable in a test tube; in an artificial environment. in vi·tro adj. In an artificial environment outside a living organism. Diagnostic test systems for the early detection and diagnosis of cancer with a focus on cervical cancer screening, the largest screening market in oncology. In collaboration with DakoCytomation A/S (Denmark), IVD (Interactive VideoDisc) See interactive video. products that apply mtm's proprietary CINtec(TM) technology to cervical biopsies (CINtec(TM) p16INK4a Histology Kit) and cytology cytology (sītŏl`əjē), in biology, the study of the structure of all normal and abnormal components of cells and the changes, movements, and transformations of such components. preparations (CINtec(TM) p16INK4a Cytology Kit) of the cervix uteri were developed and recently launched in Europe and the United States by DakoCytomation. Further biomarker-based IVD products for the rapid and automated detection of cervical cancer independent of cellular integrity are under development. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion